OLVIG
Oliver Lagore Vanvalin Investment Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55K | Buy |
+75
| New | +$2.55K | ﹤0.01% | 536 |
|
|
2024
Q4 | $2.95K | Sell |
75
-40
| -35% | -$1.57K | ﹤0.01% | 549 |
|
|
2024
Q3 | $5.4K | Hold |
115
| – | – | ﹤0.01% | 499 |
|
|
2024
Q2 | $6.21K | Hold |
115
| – | – | ﹤0.01% | 469 |
|
|
2024
Q1 | $7.84K | Hold |
115
| – | – | ﹤0.01% | 445 |
|
|
2023
Q4 | $7.2K | Sell |
115
-497
| -81% | -$31.1K | ﹤0.01% | 463 |
|
|
2023
Q3 | $27.8K | Sell |
612
-203
| -25% | -$9.21K | 0.01% | 307 |
|
|
2023
Q2 | $45.8K | Hold |
815
| – | – | 0.02% | 259 |
|
|
2023
Q1 | $36.9K | Sell |
815
-200
| -20% | -$9.05K | 0.02% | 215 |
|
|
2022
Q4 | $41.3K | Sell |
1,015
-1,050
| -51% | -$42.7K | 0.02% | 196 |
|
|
2022
Q3 | $135K | Sell |
2,065
-300
| -13% | -$19.6K | 0.09% | 103 |
|
|
2022
Q2 | $144K | Buy |
2,365
+1,200
| +103% | +$73.1K | 0.08% | 107 |
|
|
2022
Q1 | $74K | Buy |
+1,165
| New | +$74K | 0.05% | 153 |
|